Anticorps Recombinant de lapin anti-VEGFR2/CD309
VEGFR2/CD309 Recombinant Antibody for FC
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
FC
Conjugaison
Non conjugué
CloneNo.
230238B11
N° de cat : 98009-1-RR
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en cytométrie | cellules HUVEC, |
Dilution recommandée
| Application | Dilution |
|---|---|
| This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
98009-1-RR cible VEGFR2/CD309 dans les applications de FC et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | VEGFR2/CD309 Protéine recombinante Eg0218 |
| Nom complet | kinase insert domain receptor (a type III receptor tyrosine kinase) |
| Masse moléculaire calculée | 152 kDa |
| Numéro d’acquisition GenBank | NM_002253 |
| Symbole du gène | KDR |
| Identification du gène (NCBI) | 3791 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS with 0.09% sodium azide |
| Conditions de stockage | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Informations générales
VEGFR2, also named as CD309, KDR and FLK1, is a receptor for VEGF or VEGFC. VEGFR2 which belongs to the protein kinase superfamily, has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. VEGFR2 functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. Mutations of this gene are implicated in infantile capillary hemangiomas.
Protocole
| Product Specific Protocols | |
|---|---|
| FC protocol for VEGFR2/CD309 antibody 98009-1-RR | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |


